Zdrowie i gospodarka · 21/08/2025

FDA Classifies Multiplex Respiratory Panel for Emerging and Common Respiratory Pathogens

The FDA is classifying a multiplex respiratory panel to detect and identify emerging respiratory pathogens and common respiratory pathogens in human clinical specimens into Class II, special controls, to ensure safety and effectiveness while reducing regulatory burdens.